{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:32:31Z","timestamp":1768347151824,"version":"3.49.0"},"reference-count":20,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Diagn Lab Immunol"],"published-print":{"date-parts":[[1998,9]]},"abstract":"ABSTRACT<\/jats:title>The fiber-optic biosensor, originally developed to detect hazardous biological agents such as protein toxins or bacterial cells, has been utilized to quantify the concentration of serum antiplague antibodies. This biosensor has been used to detect and quantify the plague fraction 1 antigen in serum, plasma, and whole-blood samples, but its ability to quantify serum antibodies has not been demonstrated. By using a competitive assay, the concentration of serum antiplague antibodies was ascertained in the range of 2 to 15 \u03bcg\/ml. By making simple dilutions, concentrations for 11 serum samples whose antiplague antibody concentrations were unknown were determined and were found to be in good agreement with enzyme-linked immunosorbent assay results. The competitive assay method could be used to effectively determine the exposure to plague of animals or humans or could be applied to other diseases, such as hepatitis or AIDS, where the presence of antibodies is used to diagnose infection.<\/jats:p>","DOI":"10.1128\/cdli.5.5.609-612.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T19:21:10Z","timestamp":1577820070000},"page":"609-612","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":25,"title":["Quantifying Serum Antiplague Antibody with a Fiber-Optic Biosensor"],"prefix":"10.1128","volume":"5","author":[{"given":"George P.","family":"Anderson","sequence":"first","affiliation":[{"name":"Center for Bio\/Molecular Science and Engineering, Naval Research Laboratory, Washington, D.C.,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keeley D.","family":"King","sequence":"additional","affiliation":[{"name":"Geo-Centers Inc., Fort Washington,2 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn K.","family":"Cao","sequence":"additional","affiliation":[{"name":"Geo-Centers Inc., Fort Washington,2 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meagan","family":"Jacoby","sequence":"additional","affiliation":[{"name":"Center for Bio\/Molecular Science and Engineering, Naval Research Laboratory, Washington, D.C.,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances S.","family":"Ligler","sequence":"additional","affiliation":[{"name":"Center for Bio\/Molecular Science and Engineering, Naval Research Laboratory, Washington, D.C.,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Ezzell","sequence":"additional","affiliation":[{"name":"Applied Research Division, U.S. Army Medical Research Institute of Infectious Disease, Fort Detrick,3 Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(72)90006-3"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0956-5663(93)80012-E"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4049\/jimmunol.68.2.131","article-title":"Studies on immunization against plague.","volume":"68","author":"Baker E. E.","year":"1951","unstructured":"Baker E. E. Sommer H. Foster L. E. Meyer E. Meyer K. F. Studies on immunization against plague. J. Immunol. 68 1951 131 145","journal-title":"J. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(89)90662-3"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Butler T. C. Plague and other yersinia infections. 1983 Plenum Medical Book Co. New York N.Y","DOI":"10.1007\/978-1-4684-8422-9"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.2.336-341.1995"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4005(97)80109-8"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0147-9571(94)90036-1"},{"key":"e_1_3_2_10_2","unstructured":"Eigler F. S. J. Georger S. K. Bhatia J. Calvert L. C. Shriver-Lake and R. Bredehorst. December 1991. Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent. U.S. patent 5 077 210."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jmedent\/30.1.20"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1117\/1.601146"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1117\/12.58764"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0956-5663(97)00027-4"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.7589\/0090-3558-30.2.205"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.4.5.587-591.1997"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac00110a018"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1996.0006"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.7589\/0090-3558-28.4.610"},{"key":"e_1_3_2_20_2","first-page":"753","article-title":"Potency of killed plague vaccines prepared from avirulent Yersinia pestis.","volume":"58","author":"Williams J. E.","year":"1980","unstructured":"Williams J. E. Altieri P. L. Berman S. Lowenthal J. P. Cavanaugh D. C. Potency of killed plague vaccines prepared from avirulent Yersinia pestis. Bull. W. H. O. 58 1980 753 756","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_21_2","first-page":"745","article-title":"Application of enzyme immunoassay for the confirmation of clinically suspect plague in Namibia.","volume":"64","author":"Williams J. E.","year":"1986","unstructured":"Williams J. E. Arntzen L. Tyndal G. L. Isaacson M. Application of enzyme immunoassay for the confirmation of clinically suspect plague in Namibia. Bull. W. H. O. 64 1986 745 752","journal-title":"Bull. W. H. O."}],"container-title":["Clinical Diagnostic Laboratory Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.5.5.609-612.1998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.5.5.609-612.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:17:24Z","timestamp":1695568644000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.5.5.609-612.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1128\/CDLI.5.5.609-612.1998"],"URL":"https:\/\/doi.org\/10.1128\/cdli.5.5.609-612.1998","relation":{},"ISSN":["1071-412X","1098-6588"],"issn-type":[{"value":"1071-412X","type":"print"},{"value":"1098-6588","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]},"assertion":[{"value":"1998-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-05-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}